Certified French language Translation of Reasons for Order and Order rendered on 11-MAR-2010 by The Honourable Mr. Justice Campbell filed on 18-JUL-2018 pursuant to s. 20 of the Official Languages Act. Copy of Translation of Reasons for Order and Order entered in J. & O. Book, volume 1377 page(s) 438 - 441

Certified French translation of the reasons for order and order delivered 08-OCT-2009 filed on 18-JUL-2018

Certified French language Translation of Reasons for Order and Order rendered on 11-SEP-2009 by Kevin Aalto, Prothonotary filed on 18-JUL-2018 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1377 page(s) 437 - 437 and copy placed on file.

Affidavit of service of MICHAEL S. PACIOREK sworn on 16-MAR-2012 on behalf of APPLICANTS confirming service of CONSENT (DOC. 69) AND NOTICE OF DISCONTINUANCE (DOC. 70) upon all parties by telecopier on 16-MAR-2012 filed on 16-MAR-2012

Discontinuance on behalf of APPLICANTS with consent on behalf of RESPONDENT - TEVA CANADA LIMITED filed on 16-MAR-2012

Consent on behalf of APPLICANTS AND RESPONDENT - TEVA CANADA LIMITED to NOTICE OF DISCONTINUANCE filed on 16-MAR-2012

Letter from Applicant dated 23-MAR-2011 regarding Credit Reference # ARV # 1338 and discussing email correspondence between Mr. Paciorek and Mr. Claude Beaulieu, Senior Registry Officer in Ottawa regarding Cheque # T0002059 submitted to the Federal Court on July 26, 2010 and enclosing cheque in the amount of $300 (T 0002289) received on 23-MAR-2011

Transcript of hearing held at Toronto on 26-MAR-2010 received on 09-APR-2010 240 pages (including covering pages).

Transcript of hearing held at Toronto on 25-MAR-2010 received on 09-APR-2010 231 pages (including covering pages).

Transcript of hearing held at Toronto on 24-MAR-2010 received on 09-APR-2010 214 pages (including covering pages).

Transcript of hearing held at Toronto on 23-MAR-2010 received on 09-APR-2010 227 pages (including covering pages).

Memorandum to file from N. Bennett-Nelson, Toronto LO dated 13-OCT-2010 The Toronto copy of the CDs containing the Application Record, Compendium, Joint Book of Documents and Novopharm's Memo of Fact and Law were placed in the Judge's Annex. I spoke with Michael Paciorek, law clerk to the Applicant's counsel (Mr. Gaikis) who confirmed that there is nothing confidential on these CDs and I have placed the same in our "E" Annex. placed on file.

Covering letter from Respondent dated 12-AUG-2010 concerning ARV #1339, enclosing a cheque in the amount of $300.00 in full payment of fee to be paid to the Court Reporter placed on file on 17-AUG-2010

Payment of fees to the Court Reporter on behalf of the Respondents (ARV #1339), received on August 17/10 in the sum of $300.00, received on 17-AUG-2010

Order dated 29-JUL-2010 rendered by The Honourable Mr. Justice Campbell Matter considered without personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: THIS COURT ORDERS that: 1. The time limit provided for by s. 7(1)(e) of the Patented Medicines (Notice of Compliance) Regulations is hereby extended to 2-APR-2012; 2. The Application is stayed until 2-APR-2012; and 3. There shall be no costs awarded to any party with respect to this Order. Filed on 29-JUL-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1096 page(s) 165 - 166 Interlocutory Decision

Letter from Applicant to Federal Court Registry dated 26-JUL-2010 response to letter of court dated 13-JUL-2010 requesting $300 payable to the Receiver General for court reporter costs. Cheque for $300 attached. (ARV # 1338) received on 26-JUL-2010

Request to Respondents for payment of Court fees for hearing over three days (ARV # 1339) in the amount of $300.00 sent July 21, 2010

Request to the Applicants for payment of Court fees for hearing over three days (ARV # 1338) in the amount of $300.00 sent July 21, 2010

Letter from Respondent dated 30-APR-2010 regarding the letter from the Applicant with the attached decision of Justice Heneghan. received on 03-MAY-2010

Letter from Applicant dated 30-APR-2010 with an attached decision of the court- 2010 FC 447 - Henneghan J. Pfizer Canada Inc. v. Apotex Inc. filed at hearing on 30-APR-2010

Transcript of cross-examination held on 28-JUL-2009 RE: Affidavit of John M. Dietschy received at hearing on 01-APR-2010

Oral directions received from the Court: The Honourable Mr. Justice Campbell dated 16-MAR-2010 directing that " Upon review of the letter from the Respondent-Novopharm Ltd, dated Mar. 16 The Court directs, " Pursuant to Rule 117(3) leave is granted to amend the title of proceeding to reflect the recent name change of Novopharm Limited to Teva Canada Limited." placed on file on 16-MAR-2010 Confirmed in writing to the party(ies)

Supplementary Book of Authorities consisting of 1 volume(s) on behalf of Respondent- Novopharm Limited received on 24-MAR-2010

Supplementary Memorandum of fact and law on behalf of Applicant filed at hearing on 23-MAR-2010 1 judges' copies Sent directly to Presiding Judge

Supplemental Appendices A & B of the Applicants received at hearing on 23-MAR-2010

Affidavit of Alisha Schell sworn on 16-MAR-2010 on behalf of Respondent- Novopharm regarding the letter dated March 16 from the Respondent - Novopharm with Exhibits A with proof of service upon Applicant on 16-MAR-2010 filed on 16-MAR-2010

Court Reporter Invoice#6176(sitting fee)22,23,24,25-March-2010 from ASAP received on 31-MAR-2010

Toronto 22-MAR-2010 BEFORE The Honourable Mr. Justice Campbell Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Bill Evans Duration per day: 22-MAR-2010 from 09:30 to 12:00 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Jacqueline Smith 23-MAR-2010 from 09:30 to 05:00 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Jacqueline Smith 24-MAR-2010 from 09:30 to 05:30 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Jacqueline Smith 25-MAR-2010 from 09:30 to 05:00 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Jacqueline Smith 26-MAR-2010 from 09:30 to 05:30 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Jacqueline Smith Total Duration: 4.5d Appearances: Mr. Gunar A. Gaikis 416-593-5514 representing Applicant Mr. J. Sheldon Hamilton 416-593-5514 representing Applicant Ms. Nancy P. Pei 416-593-5514 representing Applicant Ms. Tracey Stott 416-593-5514 representing Applicant Mr. Jonathan Stainsby 416-643-6842 representing Respondent- Novopharm Ltd Ms. Lesley Caswell 416-643-6842 representing Respondent- Novopharm Ltd Ms. Andrew McIntyre 416-643-6842 representing Respondent- Novopharm Ltd Court Reporter: ASAP Reporting Services 416 861-8720 23-MAR-2010 Shirley S 416-861-8720 26-MAR-2010 Transcript requested by 01-APR-2010 Comments: The Respondent- submitted to court two filings- The Beck Pyrimidine compound and the Prior Art Timeline. Loose Case law submitted Minutes of Hearing entered in Vol. 821 page(s) 88 - 110 Abstract of Hearing placed on file

Order dated 25-MAR-2010 rendered by The Honourable Mr. Justice Campbell Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: dismissed in part insofar as it relates to the Patent No. 2,313,783 Filed on 25-MAR-2010 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1084 page(s) 108 - 109 Interlocutory Decision

Compendium of Documents (5 volumes) with accompanying CD-ROMS containing copy of documents contained in the application record and the Memo of Fact and Law of Novopharm Ltd. received on 18-MAR-2010

Solicitor's certificate of service on behalf of Nancy P. Pei confirming service of Compendium, Joint Book of Documents, CD upon Teva Canada Ltd, Novopharm Ltd, Minister of Health by personal service on 18-MAR-2010 filed on 18-MAR-2010

Joint Book of Documents of Astrazeneca Canada Inc. (2 VOLS) received on 18-MAR-2010

Compendium of Astrazeneca Canada Inc. (6 VOLS) received on 18-MAR-2010

Letter from Michael Paciorek, law clerk for applicant to Federal Court Registry dated 16-MAR-2010 attaching replacement pages 2785A and 2787A to be inserted in vol. 10 tab 24 of the applicant's record received on 16-MAR-2010

Letter from Respondent- Novopharm Limited dated 16-MAR-2010 regarding the recent name change of Novopharm to Teva Canada Limited as of February 16, 2010. with proof of service upon Applicant on 16-MAR-2010 received on 16-MAR-2010

Reasons for Order and Order dated 11-MAR-2010 rendered by The Honourable Mr. Justice Campbell Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 47 Result: " 1. The Motion is denied; and 2. Costs on the Motion are awarded to the Respondent Novopharm Limited." Filed on 11-MAR-2010 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Copy of Reasons for Order and Order entered in J. & O. Book, volume 1082 page(s) 225 - 228

Respondent's Record Number of copies received/prepared: 3 on behalf of Respondent filed on 08-MAR-2010

Solicitor's certificate of service on behalf of lesley caswell confirming service of doc 61, book of authorities ( 2 Volumes) upon Applicants, Respondent - The minister of Health by personal service on 08-MAR-2010 filed on 08-MAR-2010

Book of Authorities consisting of 2 volume(s) on behalf of Respondent received on 08-MAR-2010

****** CANCELLED ****** Motion Record containing the following original document(s): 58 Number of copies received: 3 on behalf of Respondent filed on 08-MAR-2010

****** CANCELLED ****** Memorandum of fact and law on behalf of Respondent: Novopharm Ltd. filed on 08-MAR-2010

Letter from Applicants dated 04-MAR-2010 enclosing coloured ink pages to replace black and white pages to be inserted into A's record received on 04-MAR-2010

Communication to the Court from the Registry dated 03-MAR-2010 re: Applicant's Motion doc. 47 sent to Court

Solicitor's certificate of service on behalf of TRACEY L. SCOTT confirming service of DOC 56 upon RESPONDENTS (NOVOPHARM LIMITED AND MINISTER OF HEALTH) by personal service on 26-FEB-2010 filed on 26-FEB-2010

Reply Representations on behalf of Applicant in response to the opposing submissions doc. No. 54 to the Motion in writing Filed on 26-FEB-2010

Solicitor's certificate of service on behalf of Keya Dasgupta confirming service of Doc 54 upon all parties by personal service on 22-FEB-2010 filed on 22-FEB-2010

Motion Record in response to Motion Doc. No. 47 containing the following original document(s): 52 53 Number of copies received: 3 on behalf of Respondent - Novopharm Ltd. filed on 22-FEB-2010

Written Representations contained within a Motion Record on behalf of Respondent - Novopharm Ltd. concerning Motion Doc. No. 47 filed on 22-FEB-2010

Affidavit of Alisha Schell sworn on 22-FEB-2010 contained within a Motion Record on behalf of Respondent - Novopharm Ltd. in opposition to Motion Doc. No. 47 with Exhibits A-D filed on 22-FEB-2010

Covering letter from ASTRAZENECA CANADA dated 12-FEB-2010 concerning Doc. Nos. 50 51 placed on file on 12-FEB-2010

Solicitor's certificate of service on behalf of Tracey L. Stott confirming service of doc 50 upon Respondent(Novopharm) and Respondent(Minister of Health) by personal service on 12-FEB-2010 filed on 12-FEB-2010

Motion Record containing the following original document(s): 47 48 49 Number of copies received: 3 on behalf of ASTRAZENECA CANADA filed on 12-FEB-2010

Written Representations contained within a Motion Record on behalf of ASTRAZENECA CANADA concerning Motion Doc. No. 47 filed on 12-FEB-2010

Affidavit of Michael S. Paciorek sworn on 12-FEB-2010 contained within a Motion Record on behalf of ASTRAZENECA CANADA in support of Motion Doc. No. 47 with Exhibits A filed on 12-FEB-2010

Notice of Motion contained within a Motion Record on behalf of ASTRAZENECA CANADA in writing to be placed before the Court in Ottawa for an Order That the video-recordings of the cross-examination in this proceeding may be filed with the court as a supplemental volume to the Application Record and other relief. filed on 12-FEB-2010

Oral directions received from the Court: The Honourable Mr. Justice Campbell dated 27-JAN-2010 directing that 1.If the applicant will rely on a PowerPoint presentation during the hearing then this should be sent to the Respondents not later than March 1-10. 2. All parties should serve and file preliminary motions no later than March 1-2010. placed on file on 27-JAN-2010 Confirmed in writing to the party(ies)

Toronto 27-JAN-2010 BEFORE The Honourable Mr. Justice Campbell Language: E Before the Court: Pre-Trial Conference to discuss the contents of the Respondent's(Novopharm) letter dated 8-jan-10 Result of Hearing: The court agrees to the addition of an extra day to the hearing, in order to have a 'primer' session prior to the commencement of the hearing. Also, if the Applicant will rely on a PowerPoint presentation, it should be sent to the Respondent no later than March 1, 2010, further all parties should serve and file preliminary motions no later than March 1, 2010. held by way of Conference Call Duration per day: 27-JAN-2010 from 01:00 to 01:30 Courtroom : Teleconference Room No. 1 - Toronto Court Registrar: Jacqueline Smith Total Duration: 30min Appearances: Mr. Sheldon Hamilton 416-593-5514 representing Applicant Ms. Nancy Pei 416-593-5514 representing Applicant Mr. John Stainsby 416-360-8425 representing Respondent Ms. Lesley Caswell 416-360-8425 representing Respondent Minutes of Hearing entered in Vol. 817 page(s) 233 - 235 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Tracey L. Stott confirming service of Doc. No. 45 upon all respondents by personal service on 15-JAN-2010 filed on 15-JAN-2010

Application Record (20 volumes) + Appendices A&B (3 volumes) Number of copies received/prepared: 3 on behalf of Applicants filed on 15-JAN-2010

Letter from Respondent dated 08-JAN-2010 requesting a CMC with the Judge hearing the Application received on 08-JAN-2010

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 07-JAN-2010 directing that "Send correspondence to counsel for Astra & Novo. Have CMT arrange a CMC with counsel on this file." placed on file on 07-JAN-2010

Communication to the Court from the Registry dated 29-DEC-2009 re: Letter of Steven M. Teal, Student at Law, Goodmans LLP dated December 24, 2009 forwarded to the Court for direction as to whether Exhibit F, CD may be reviewed.

Letter from Steven M. Teal, Student at Law, Goodmans LLP to Federal Court dated 24-DEC-2009 As per your request, this letter serves as a formal request to review the affidavit evidence of Dr. William R. Roush in AstroZeneca Canada Inc. v. Novopharm Limited and Miniter of Health, Court File No. T-1636-08. The affidavit evidence of Dr. Roush should be contained in Exhibit F, which is a CD. Exhibit F is supposed to contain "AstraZeneca's Evidence", as outlined in paragraph 6 of the Notice of Motion. The court index and docket does not suggest that this evidence is confidential or protected under a sealing order. If you have any further questions regarding this request, you can reach me at the contact information provided in this letter received on 29-DEC-2009

Letter from counsel of the Respondent Novopharm Ltd. expressing concerns regarding the dated 01-OCT-2009 expressing concerns regarding the appointing of hearing dates on files T-1636-08 and T-1972-08. received on 01-OCT-2009

Order (time and place) dated 13-OCT-2009 rendered by Chief Justice Lutfy and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Toronto on 22-MAR-2010 to begin at 09:30 duration: 4d language: E Filed on 14-OCT-2009 cc's sent to parties entered in J. & O. Book, volume 1067 page(s) 431 - 431 Transmittal letters placed on file

Reasons for Order and Order dated 08-OCT-2009 rendered by The Honourable Mr. Justice Kelen Matter considered without personal appearance The Court's decision is with regard to Order dated 11-SEP-2009 Result: dismissed This appeal is dismissed with costs to Novopharm in the cause; Filed on 08-OCT-2009 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Copy of Reasons for Order and Order entered in J. & O. Book, volume 1067 page(s) 341 - 345

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 01-OCT-2009 directing that "Further to correspondence from the Respondent Novopharm Limited dated 29-SEP-2009, the Court grants the amendements to the schedule as set out in the letter. 1) Cross examinations to be completed by 13-NOV-2009; 2) Applicant's Record to be served and filed by 15-JAN-2010; 3) Respondent's Record to be served and filed by 08-MAR-2010; and 4) Hearing Date on 22-MAR-2010." placed on file on 05-OCT-2009 Confirmed in writing to the party(ies)

Letter from the Respondent - Novopharm dated 29-SEP-2009 proposed timetable for this file. received on 29-SEP-2009

Toronto 28-SEP-2009 BEFORE The Honourable Mr. Justice Kelen Language: E Before the Court: Motion Doc. No. 33 on behalf of Applicant Appeal Prothonotary decision Result of Hearing: Matter dismissed held in Court Senior Usher: Greg Nevin Duration per day: 28-SEP-2009 from 12:30 to 02:25 Courtroom : Courtroom No. 5-C - Toronto Court Registrar: Jim Outtrim Total Duration: 1h55min Appearances: Mr.Gunars A.Gaikis 416-593-5514 representing Applicant Ms.Urszula Wojtyra 416-593-593-5514 representing Applicant Mr.Jonathan Stainsby 416-360-3568 representing Respondent,Novopharm Ms.Lesley Caswell 416-360-6336 representing Respondent,Novopharm Mr.Andrew McIntyre 416-360-6336 representing Respondent,Novopharm No one appearing . representing Respondent, The Minister of Health Comments: Order to be issued. The Court ordered costs in the cause. Minutes of Hearing entered in Vol. 809 page(s) 395 - 397 Abstract of Hearing placed on file

Toronto 25-SEP-2009 BEFORE The Honourable Mr. Justice Kelen Language: E Before the Court: Motion Doc. No. 33 on behalf of Applicant Discussion with the parties pursuant to direction of the Court Result of Hearing: The motion (doc.33) will go ahead on September 28,2009 held by way of Conference Call in chambers The Court was in chambers in Ottawa, the court registrar was in Toronto Duration per day: 25-SEP-2009 from 02:30 to 02:40 Courtroom : Judge's Chambers - Toronto Court Registrar: Jim Outtrim Total Duration: 10min Appearances: Mr.Gunars A Gaikis 416-593-5514 representing Applicant Mr.Jonathan Stainsby 416-360-3568 representing respondent,Novopharm No one appearing . representing Respondent,The Minister of Health Minutes of Hearing entered in Vol. 809 page(s) 370 - 371 Abstract of Hearing placed on file

Toronto 25-SEP-2009 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the court informs the parties the timetable will be approved, a further case management conference is scheduled for October 1, 2009 the court will issue a direction setting down the hearing date for March 2010. held by way of Conference Call in chambers Duration per day: 25-SEP-2009 from 11:30 to 11:45 Courtroom : Judge's Chambers - Toronto Court Registrar: Mary Sansone Total Duration: 15min Appearances: Gunars Gaikis 416 593-5514 representing Defendant Applicant Jonothan Stainsby 416 360-3568 representing Respondent, Novopharm Minutes of Hearing entered in Vol. 809 page(s) 348 - 349 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of Doc. 41--Responding Motion Record of Novopharm Limited upon the Applicants and the Respondent--the Minister of Health by personal service on 25-SEP-2009 filed on 25-SEP-2009

Motion Record in response to Motion Doc. No. 33 containing the following original document(s): 40 Number of copies received: 3 on behalf of Respondent--Novopharm Limited filed on 25-SEP-2009

Written Representations contained within a Motion Record on behalf of Respondent-- Novopharm Limited concerning Motion Doc. No. 33 filed on 25-SEP-2009

Oral directions received from the Court: The Honourable Mr. Justice Kelen dated 25-SEP-2009 directing that The Court requests that a teleconference be scheduled in order to discuss the possibility of granting leave for AstraZenaca to file Reply evidence in response to Novopharm Reply evidence. Thisis proposed as seemingly logical way of settling the appeal (motion doc.33), and to bring all relevant material before the Court. Also,if the motion goes ahead on September 28,2009, it will commence at 12 noon. placed on file on 25-SEP-2009

Correction to General Sitting concerning Motion Doc. No. 34 Hearing removed from General Sitting at Toronto on 28-SEP-2009 Reason for correction: Notice of Motion already filed on 21-SEP-09

Solicitor's certificate of service on behalf of Urszula Wojtyra confirming service of doc 38 and book of Authorities upon Respondents by personal service on 23-SEP-2009 filed on 23-SEP-2009

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 23-SEP-2009

Motion Record containing the following original document(s): 34 35 36 37 Number of copies received: 3 on behalf of Applicant filed on 23-SEP-2009

Written Representations on behalf of Applicant concerning Motion Doc. No. 34 filed on 23-SEP-2009

Affidavit of Alisha Schell sworn on 25-JUN-2009 on behalf of Applicant in support of Motion Doc. No. 34 with Exhibits A,B,C,D,E,F filed on 23-SEP-2009

Affidavit of Donna L. Romero sworn on 25-JUN-2009 on behalf of Applicant in support of Motion Doc. No. 34 filed on 23-SEP-2009

Notice of Motion on behalf of Applicant returnable at General Sitting in Toronto on 28-SEP-2009 to begin at 09:30 duration: 2h language: E for an Order setting aside paragraphs 1 and 3 of the Order of Prothonotary Aalto dated 11-SEP-2009. Smart & Biggar Gunars A. Gaikis (416 593 5514) filed on 23-SEP-2009

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 21-SEP-2009 directing that A case management conference will be held via teleconference 25-SEP-2009 at 11:30am. placed on file on 21-SEP-2009 Confirmed in writing to the party(ies)

Notice of Motion on behalf of Applicant returnable at General Sitting in Toronto on 28-SEP-2009 to begin at 09:30 duration: 2h language: E for an appeal of the decision of Kevin Aalto, Prothonotary dated 11-SEP-2009 (Nancy Pei 416-593-5514) (CMJ: Aalto, P) with proof of service upon all parties on 21-SEP-2009 filed on 21-SEP-2009

Letter from Novopharm Limited, Respondent dated 18-SEP-2009 in response to Applicant's correspondence dated 18-SEP-2009. received on 18-SEP-2009

Letter from Applicant dated 18-SEP-2009 in response to Novopharm Limited's correspondence dated 17-SEP-2009 attached. received on 18-SEP-2009

Letter from Novopharm Limited, Respondent dated 17-SEP-2009 requesting Court to approve the proposed revised schedule and permit the filing of the enclosed Requisition for Hearing. received on 17-SEP-2009

Reasons for Order and Order dated 11-SEP-2009 rendered by Kevin Aalto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 23 Result: The Court Orders that: 1) The Repondent, Novopharm Limited, is granted leave to file the proposed reply affidavits of Drs. Romero, Grieco and Scallen in accordance with the reasons given herein. 2) The balance of the motion is dimissed. 3) Cost of the motion to Novopharm Limited, in any event of the cause. Filed on 11-SEP-2009 certified copies sent to parties Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1065 page(s) 209 - 209

E-mail (Letter) from Novopharm requesting a CMC to schedule the proposed AstraZeneca motions and create a timetable. received on 09-SEP-2009

Notice of Change of Address on behalf of Respondent Novopharm (Heenan Blaikie) received on 24-AUG-2009

Toronto 16-JUL-2009 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: The parties came to an agreement with regard to the videotaping of the upcoming cross-examinations. held in chambers Duration per day: 16-JUL-2009 from 12:40 to 01:00 Courtroom : Judge's Chambers - Toronto Court Registrar: Rochelle Dickenson Total Duration: 20min Appearances: Gunars Gaikis/Nancy Pei 416.593.5514 representing Astrazeneca Jonathan Stainsby/Bill Mayo/Neil Feinberg 416.360.3568 representing Novopharm Minutes of Hearing entered in Vol. 806 page(s) 321 - 322 Abstract of Hearing placed on file

Toronto 23-JUL-2009 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Motion Doc. No. 23 on behalf of Defendant Result of Hearing: Matter reserved Cross-exams to go ahead as planned. held in Court Senior Usher: Ron Cooksey Duration per day: 22-JUL-2009 from 10:10 to 04:00 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Rochelle Dickenson Total Duration: 6h Appearances: Jonathan Stainsby/Lesley Caswell 416.360.6336 representing Novopharm Gunars Gaikis/Ursula Wojtyra 416.593.5514 representing Astrazeneca Minutes of Hearing entered in Vol. 806 page(s) 211 - 218 Abstract of Hearing placed on file

Letter from Applicant dated 26-JUN-2009 regarding the case management conference dated 02-JUN-2009 and upcoming conference 02-JUL-2009 related to the motion proposed by Novopharm Limited. received on 26-JUN-2009

Letter from Novopharm Limited, Respondent dated 15-JUL-2009 in response to Applicant's letter dated 15-JUL-2009 and direction dated 13-JUL-2009. received on 15-JUL-2009

Solicitor's certificate of service on behalf of Urszula Wojtyra confirming service of Doc. 30 and the Joint Book of Authorities upon the Respondents by personal service on 17-JUL-2009 filed on 17-JUL-2009

Joint Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 17-JUL-2009

Motion Record in response to Motion Doc. No. 23 containing the following original document(s): 29 Number of copies received: 3 on behalf of Applicant filed on 17-JUL-2009

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 23 filed on 17-JUL-2009

Letter from Applicant dated 15-JUL-2009 further to the letter dated 13-JUL-2009 and the direction dated 13-JUL-2009. received on 15-JUL-2009

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 13-JUL-2009 directing that A Case Management Conference be held via teleconference 16-JUL-2009 at 12:30pm. placed on file on 13-JUL-2009 Confirmed in writing to the party(ies)

Letter from Novopharm Limited, Respondent dated 13-JUL-2009 in response to Applicants' letter dated 13-JUL-2009. received on 13-JUL-2009

Letter from Applicant dated 13-JUL-2009 requesting urgent case management conference in this matter. received on 13-JUL-2009

Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of doc 27 and book of authorties upon Applicant Respondent by personal service on 10-JUL-2009 filed on 10-JUL-2009

Book of Authorities consisting of 1 volume(s) on behalf of Respondent received on 10-JUL-2009

Motion Record containing the following original document(s): 23 24 25 26 Number of copies received: 3 on behalf of Respondent filed on 10-JUL-2009

Written Representations contained within a Motion Record on behalf of Respondent concerning Motion Doc. No. 23 filed on 10-JUL-2009

Affidavit of Alisha Schell sworn on 25-JUN-2009 contained within a Motion Record on behalf of Respondent in support of Motion Doc. No. 23 with Exhibits A-F filed on 10-JUL-2009

Affidavit of Dr. Donna L. Romero sworn on 25-JUN-2009 contained within a Motion Record on behalf of Respondent in support of Motion Doc. No. 23 filed on 10-JUL-2009

Notice of Motion contained within a Motion Record on behalf of Respondent returnable at Special Sitting in Toronto on 23-JUL-2009 to begin at 10:00 for an Order striking out the Notice of Application filed on 10-JUL-2009

Toronto 02-JUL-2009 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the motion previously scheduled to be heard on July 7, 2009 is adjourned to July 23, 2009 beginning at 10:00 a.m. The Respondent's motion Record is due on July 10, 2009 and the responding record is due on July 17, 2009. held in chambers Duration per day: 02-JUL-2009 from 10:00 to 10:30 Courtroom : Judge's Chambers - Toronto Court Registrar: Stan Shepherd Total Duration: 30 Min Appearances: Gunnars gaikis, Nancy Pei, Ms. Wojytera 416-593-5514 representing Applicant Bill Mayo, Lesley Caswell 416-643-6842 representing Respondent Minutes of Hearing entered in Vol. 805 page(s) 272 - 276 Abstract of Hearing placed on file

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 17-JUN-2009 directing that the deadline for cross-examinations as provided in paragraph (f) of Schedule "A" of the Order of Prothonotary Aalto dated January 30, 2009 is extended to August 31, 2009. The balance of the schedule shall proceed according to Schedule "A" of the January 30, 2009 Order. placed on file on 17-JUN-2009 Confirmed in writing to the party(ies)

Letter from Respondent dated 22-JUN-2009 RE: CMC SCHEDULED FOR 23-JUN-2009 AT 9:00AM WITH CD CONTAINING ASTRAZENECA AND NOVOPHARM LIMITED'S EVIDENCE IN CHIEF AND NOVOPHARM LIMITED'S PROPOSED REPLY EVIDENCE ATTACHED. received on 22-JUN-2009

Memorandum to file from Garnet Morgan dated 19-JUN-2009 the CMC for June 23, 2009 has been rescheduled from 9:00 AM to 10:00 AM on that same day. The parties have confirmed their availability (Ms. Pei & Ms. Caswell)._ placed on file.

Letter from Applicant dated 04-JUN-2009 further to the case management conference held on 03-JUN-2009. The Parties provide language for a Direction to implement the extension to the deadline for cross-examiniations. received on 04-JUN-2009

Toronto 03-JUN-2009 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Next CMC June 23, 2009 for a duration of 30 minutes. Motion for reply evidence July 7 10am for 1.5hrs. held in chambers Duration per day: 03-JUN-2009 from 02:00 to 02:30 Courtroom : Judge's Chambers - Toronto Court Registrar: Rochelle Dickenson Total Duration: 30min Appearances: Nancy Pei 416.593.5514 representing Applicant Gunars Gaikis 416.593.5514 representing Applicant Lesley Caswell 416.643.6842 representing Novopharm Respondent Bill Mayo 416.643.6842 representing Respondent Novopharm Comments: Novopharm to complete draft reply affidavits by June 12/09. Astrazeneca to review the reply affidavits by June 19/09 in order to discuss the issue at the CMC on June 23, 2009. Mr. Gaikis is to provide his client's affidavits (text only) to the court. If necessary Ms. Caswell will supply the Court with her draft reply affidavits by June 22/09. A proposed timetable will be submitted by the parties for the Court's review. If necess ary a motion for reply evidence will be heard on July 7 at 10am for a duration of 1.5 hrs. Minutes of Hearing entered in Vol. 803 page(s) 315 - 316 Abstract of Hearing placed on file

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 26-MAY-2009 directing that On consent of Novopharm Limited, paragraph (c) of Schedule "A" of the Order of Prothonotary Aalto is varied to permit the service of the Applicants' evidence on validity of the '945 patent by May 27, 2009 in respect of US- based witnesses. This variation shall not impact the balance of the schedule. In addition to this, a case conference will be held on June 3, 2009 at 2:00pm by way of telephone for an estimated duration of 30 minutes. placed on file on 27-MAY-2009 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 19-MAY-2009 requesting an amendment to the schedule and a case conference. received on 19-MAY-2009

Letter from Applicants dated 20-FEB-2009 re: requesting (on consent) the order of the court with regard to disclosure information received on 20-FEB-2009

Order dated 24-FEB-2009 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from the Applicants (on consent of the parties) dated 24-FEB-2009 Result: 1. The Minister shall, within 30 days of the date of this Order, verify that the bundle of documents entitled, "Novopharm's disclosure with respect to its formulation" provided by counsel for Novopharm to counsel for the Appli cants on Nov. 25, 2008...corresponds fully to the information currently in the submission filed by Novopharm for a notice of compliance for rosuvastati n calcium tablets for oral administration in strengths of 5, 10, 20 and 40 mg; 2. Novopharm shall produce to Astrazeneca Canada any change made to the disc losure during the pendency of this proceeding as it is made or if already made, to produce any such changes to AstraZeneca Canada and the Minister within 30 days of the date of this ORder; and 3. The Minister shall, within 30 days of receipt of any changes referred to in paragraph (ii), verify that such changes correspond fully to the informat ion in the submission filed by Novopharm for a notice of compliance for rosu vastatin calcium tablets for oral administration in strengths of 5, 10, 20 and 40 mg. 4. In the event that the verification referred to in paragraph 1 indicates that the formulation set out in Novopharm's Disclosure is not the same as the formulation in Novopharm's Abbreviated New Drug Submission or pursuant to paragraph 2, Novopharm produces changes to the Disclosure where such changes relate to a change in the formulation, the Applicants will have thirty days following the later of (a) the receipt of the verification referred to in paragraph 1 and (b) the production of any changes to Novophar m's Disclosure pursuant to paragraph 2 to file evidence on infringement of Canadian Patent No. 2,313,783. Filed on 24-FEB-2009 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1047 page(s) 311 - 313 Interlocutory Decision

Order dated 30-JAN-2009 rendered by Kevin Aalto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 10 Result: 1. Applicant to serve their evidence on infringment no later than 90 days from Nov25/08. 2. Novopharm shall serve its evidence on validity no later than 90 days from Nov 25/08. 3. Applicants shall serve their evidence on validity no later than 90 days from the date of service of Novopharm's evidence on validity 4. The corporate parties shall request a case conference within 1 week of delivery of applicant's evidence on validity to discuss a possible motion for reply evidence. 5. Cross-examinations on all issues shall be completed within 75 days 6. A's Record shall be served and filed within 45 days of completion of cross-examinations 7. Novopharm's Record shall be served and filed within 45 days of the service of A's Record. Filed on 30-JAN-2009 entered in J. & O. Book, volume 1045 page(s) 235 - 240 Interlocutory Decision

Protective Order dated 24-DEC-2008 rendered by Kevin Aalto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: granted Filed on 24-DEC-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1042 page(s) 403 - 415 Interlocutory Decision

Communication to the Court from the Registry dated 18-NOV-2008 re: letter on consent to make file specially managed

Order dated 11-DEC-2008 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: "...Prothonotary Kevin Aalto is assigned as Case Management Judge in this matter." Filed on 12-DEC-2008 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1041 page(s) 488 - 488 Interlocutory Decision

Oral directions received from the Court: Kevin Aalto, Prothonotary dated 09-DEC-2008 directing that "The parties have provided a draft protective order on consent for consideration by the Court. The designation of "confidential information" in par. 5(b)refers to "all information relating to the patents(s) at issue in the proceeding.". This description is too vague and wide in its ambit. The parties may either send to the Court a letter advising of what is meant by this paragraph or provide a revised draft of this paragraph that is not as vague or all encompassing. Alternatively, if required, the parties may request a case conference to review the inclusion of this clause in the order." placed on file on 09-DEC-2008 Confirmed in writing to the party(ies)

Toronto 02-DEC-2008 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Motion Doc. No. 10 on behalf of Applicant Result of Hearing: Matter reserved held in Court Senior Usher: John Jasenic Duration per day: 02-DEC-2008 from 10:10 to 10:45 Courtroom : Judge's Chambers - Toronto Court Registrar: Natashia Bennett-Nelson Total Duration: 35min Appearances: Mr. J. Sheldon Hamilton / Mr. Josesph Fraresso (416) 593-5514 representing Applicant Ms. Lesley Caswell / Ms. Sandra Barton (416) 360-6336 representing Respondent, Novopharm Draft Decision to be submitted by Applicant Comments: The Court directed the parties to consult with one another and submit a revised proposed timetable Minutes of Hearing entered in Vol. 790 page(s) 208 - 211 Abstract of Hearing placed on file

Correction to General Sitting concerning Motion Doc. No. 10 Hearing removed from General Sitting at Toronto on 01-DEC-2008 Reason for correction: matter will be heard at special sitting in Toronto on 2-DEC_2008 at 10:00am before Aalto P.

Letter from Applicants dated 28-NOV-2008 in reply to Novopharm's letter dated November 28, 2008. received on 28-NOV-2008

Letter from Respondent - Novopharm Ltd. dated 28-NOV-2008 communicating its desire to have the Applicants' motion proceed as agreed upon by counsel at general sittings on December 1, 2008. received on 28-NOV-2008

Letter from Applicants dated 27-NOV-2008 proposing to adjourn their motion (returnable December 1, 2008 in Toronto) to a time and place before Prothonotary Aalto, who has recently been assigned as case manager. received on 28-NOV-2008

Solicitor's certificate of service on behalf of Andrew McIntrye confirming service of doc 17 upon all parties by hand on 28-NOV-2008 filed on 28-NOV-2008

Motion Record in response to Motion Doc. No. 10 containing the following original document(s): 15 16 Number of copies received: 3 on behalf of Respondent (Novopharm) filed on 28-NOV-2008

Written Representations contained within a Motion Record on behalf of Respondent (Novopharm) concerning Motion Doc. No. 10 filed on 28-NOV-2008

Affidavit of Alisha Meredith sworn on 28-NOV-2008 contained within a Motion Record on behalf of Respodnent (Novopharm) in opposition to Motion Doc. No. 10 with Exhibits A-D filed on 28-NOV-2008

Solicitor's certificate of service on behalf of Nancy P. Pei confirming service of Doc. 13 and the Applicant's Book of Authorities upon Applicant by personal service on 25-NOV-2008 filed on 25-NOV-2008

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 25-NOV-2008

Motion Record containing the following original document(s): 10 11 12 Number of copies received: 3 on behalf of Applicant filed on 25-NOV-2008

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 10 filed on 25-NOV-2008

Affidavit of Jacinta M. De Abreu sworn on 25-NOV-2008 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 10 with Exhibits A-G filed on 25-NOV-2008

Notice of Motion contained within a Motion Record on behalf of Applicant returnable at General Sitting in Toronto on 01-DEC-2008 to begin at 09:30 duration: 2h language: E for an Order directing the parties adhere to the procedural schedule annexed as Schedule "A" to this notice of motion, including the requirement that the Respondent, Novopharm Limited, serve its evidence on teh alleged invalidity of Canadian Patent NO. 2,072,945 before the service of the Applicant's evidence on the allegation of invalidity; and other relief. (Gunars Gaikis 416-593-5514) filed on 25-NOV-2008

Letter from MR. WILLIAM P. MAYO (COUNSEL FOR RESPONDENT - NOVOPHARM) dated 07-NOV-2008 "...NOVOPHARM RESPECTFULLY REQUESTS THAT A CASE MANAGEMENT JUDGE OR PROTHONOTARY BE APPOINTED AND THAT A CASE MANAGEMENT CONFERENCE BE SCHEDULED AT THE EARLIEST POSSIBLE OPPORTUNITY TO ADDRESS SCHEDULING AND RELATED ISSUES..." received on 10-NOV-2008

Letter from Applicant dated 07-NOV-2008 requesting, on consent of parties, that this matter be specially managed by a Judge or Prothonotary Aalto or Milczynski (cc'd to all parties) received on 07-NOV-2008

Affidavit of service of Jeff Connor sworn on 31-OCT-2008 on behalf of Applicants confirming service of Doc. No. 1 upon Respondent - Novopharm Ltd. by personal service on 23-OCT-2008 filed on 03-NOV-2008

Affidavit of service of Timothy Law sworn on 24-OCT-2008 on behalf of Applicants confirming service of Doc. No. 1 upon Respondent - Minister of Health (TOR) by personal service on 23-OCT-2008 filed on 03-NOV-2008

Affidavit of service of P. Claire Gordon sworn on 23-OCT-2008 on behalf of Applicants confirming service of Doc. No. 1 upon Respondent - Minister of Health (OTT) by personal service on 23-OCT-2008 filed on 03-NOV-2008

Solicitor's certificate of service on behalf of William Mayo confirming service of Doc. 5 upon Applicant and the Respondent, The Minister of Health by telecopier on 27-OCT-2008 filed on 27-OCT-2008

Notice of appearance on behalf of Respondent, Novopharm Limited filed on 27-OCT-2008

Affidavit of service of Christine Lavoie sworn on 27-OCT-2008 on behalf of Resp- Min of Health confirming service of Doc 3 upon all parties by telecopier on 27-OCT-2008 with Exhibits a,b filed on 27-OCT-2008

Notice of appearance on behalf of Resp-Min of Health filed on 27-OCT-2008

Service copy of Doc. No. 1 with proof of service upon Respondent (Minister) on 24-OCT-2008 filed on 24-OCT-2008

Notice of application and 2 copies with regard to Judicial Review (s.18) filed on 23-OCT-2008 Tariff fee of $50.00 received: yes